Abridge launched into the healthcare market eight years ago as an artificial intelligence scribe, but the company has been steadily building out its tech to function more like an AI assistant across ...
Already available through Abridge's AI-driven clinical decision support (CDS) technology are insights from Wolters Kluwer Health's UpToDate. But later this year, medical research data from NEJM and ...
Deployment of artificial intelligence for point-of-care clinical decision support is in its nascency. Despite the media attention and proliferation of AI studies, translation to clinical practice is ...
Amber Nigam is CEO and cofounder of basys.ai, a Harvard-based company streamlining prior authorization for health plans with generative AI. A few years ago, artificial intelligence (AI) promised to ...
Abridge is expanding its clinical decision support tool through two partnerships with publishers of major medical journals, the AI scribe company announced Wednesday. Under the deal, content from the ...
The Biden administration has released a sweeping new rule touching on multiple aspects of health information technology in the U.S., including proposals meant to create more transparency and trust in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results